Hero Image

Diversity & inclusion fuels our mission

We are deeply committed to fostering an inclusive environment that embraces and values varied skills, experiences, backgrounds, and cultural perspectives. MSD has a long-standing commitment to creating an organisation that is diverse and a culture that is inclusive and socially responsible.

Our workforce represents the people we serve

Diversity and inclusion (D&I) are not just words – they are the reason we are able to deliver on our promise to invent for life. We foster a diverse workforce where employees feel comfortable bringing their unique perspectives and their whole self to work.

Māori language Day Tipu – To Grow
A man and a boy are sitting in the kitchen and playing
Putting the Parents back in Parental Leave

Our diversity & inclusion by the numbers worldwide

51%

new hires were female in 2018

View careers
17K

EBRG members

Learn more
15K

diverse suppliers globally

Visit suppliers

But diversity is only half of the story; inclusion is just as important. Inclusion means a sense of belonging. When our employees know they are crucial to our mission, not only will they thrive, but our company will, too.

Stories that inspire our progress

Together, we achieve more when we bring our whole selves to work.

View our stories

Working together to detect lung cancer earlier

Vicki Goodman, vice president, therapeutic area head, oncology late-stage development, reports on encouraging progress in lung cancer screening around the world

Read more

Next: Working together to detect lung cancer earlier

Understanding melanoma: The signs, symptoms and risk factors

What is melanoma? Melanoma is the most serious form of skin cancer. Characterised by the uncontrolled growth of pigment-producing cells, melanoma accounts for approximately 2% of new cancer cases worldwide. Melanomas can occur anywhere on the skin, including areas without sun exposure, but they are more likely to start in certain locations. The average age […]

Read more

Next: Understanding melanoma: The signs, symptoms and risk factors

Women in science? Absolutely.

Strong career paths and cutting-edge science draw more women to our small molecule process R&D team

Read more

Next: Women in science? Absolutely.

Introducing our global hybrid working model

Over the last year, the global pandemic has created profound challenges — for the world, for our industry, for our own families. We are proud and grateful to see how the people of our company have looked out for each other and carried out our urgent mission on behalf of our customers and patients. It […]

Read more

Next: Introducing our global hybrid working model

Working together to detect lung cancer earlier

Vicki Goodman, vice president, therapeutic area head, oncology late-stage development, reports on encouraging progress in lung cancer screening around the world

Read more

Next: Working together to detect lung cancer earlier

Understanding melanoma: The signs, symptoms and risk factors

What is melanoma? Melanoma is the most serious form of skin cancer. Characterised by the uncontrolled growth of pigment-producing cells, melanoma accounts for approximately 2% of new cancer cases worldwide. Melanomas can occur anywhere on the skin, including areas without sun exposure, but they are more likely to start in certain locations. The average age […]

Read more

Next: Understanding melanoma: The signs, symptoms and risk factors

Women in science? Absolutely.

Strong career paths and cutting-edge science draw more women to our small molecule process R&D team

Read more

Next: Women in science? Absolutely.

Introducing our global hybrid working model

Over the last year, the global pandemic has created profound challenges — for the world, for our industry, for our own families. We are proud and grateful to see how the people of our company have looked out for each other and carried out our urgent mission on behalf of our customers and patients. It […]

Read more

Next: Introducing our global hybrid working model

Previous
Next

Reference:
MSD Data on File

NZ-NON-00192 Last Updated September 2021